MetaVia Inc Share Price Today: Live Updates & Key Insights
MetaVia Inc share price today is $1.39, up -4.73%. The stock opened at $1.46 against the previous close of $1.48, with an intraday high of $1.4786 and low of $1.38.
MetaVia Inc Share Price Chart
MetaVia Inc
MetaVia Inc Share Price Performance
MetaVia Inc Institutional Holdings
MetaVia Inc Market Status
MetaVia Inc Fundamentals
Market Cap 4.67 M
PB Ratio 0.775
PE Ratio 0.0
Enterprise Value -9.29 M
Total Assets 16.26 M
Volume 121459
MetaVia Inc Company Financials
About MetaVia Inc & investment objective
Company Information MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, as well as completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus; and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in Phase 1 trial for the treatment of obesity. The company's therapeutic programs include ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 for the treatment of cognitive impairment; and Gemcabene for the treatment of dyslipidemia. It has a license agreement with Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene; and Dong-A ST, a sole manufacturer for the production of DA-1241 and DA-1726. The company was formerly known as NeuroBo Pharmaceuticals, Inc. and changed its name to MetaVia Inc. in November 2024. MetaVia Inc. is headquartered in Cambridge, Massachusetts. MetaVia Inc. operates as a subsidiary of Dong-A ST Co., Ltd.
Organisation Biotechnology
Employees 9
Industry Biotechnology
CEO Mr. Heon Kim Hyung
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
MetaVia Inc FAQs
What is the share price of MetaVia Inc today?
The current share price of MetaVia Inc is $1.39.
Can I buy MetaVia Inc shares in India?
Yes, Indian investors can buy MetaVia Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy MetaVia Inc shares in India?
You can easily invest in MetaVia Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy MetaVia Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of MetaVia Inc.
Can I buy fractional shares of MetaVia Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of MetaVia Inc?
MetaVia Inc has a market cap of $4.67 M.
In which sector does MetaVia Inc belong?
MetaVia Inc operates in the Biotechnology sector.
What documents are required to invest in MetaVia Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of MetaVia Inc?
The PE ratio of MetaVia Inc is N/A and the PB ratio is 0.78.